Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
78°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Scholar Rock
< Previous
1
2
3
Next >
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 16, 2024
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Reports Second Quarter 2024 Financial Results and Highlights Business Progress
August 08, 2024
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock to Host Conference Call to Discuss Second Quarter 2024 Financial Results and Provide Business Update on August 8, 2024
July 23, 2024
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 12, 2024
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Announces New SRK-439 Preclinical Data Showing Significant Lean Mass Preservation and Attenuation of Fat Mass Rebound Following GLP-1 Receptor Agonist Withdrawal
June 24, 2024
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 18, 2024
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Presents New Data from SRK-181 Phase 1 DRAGON Trial at ASCO 2024 Annual Meeting
June 03, 2024
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock to Present New Data from SRK-181 Phase 1 DRAGON Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting
May 28, 2024
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Announces Initiation of Phase 2 EMBRAZE Trial of Apitegromab in Obesity and New Preclinical Data Supporting SRK-439 in Obesity
May 22, 2024
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock to Participate in Upcoming Investor Conferences
May 20, 2024
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 17, 2024
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock to Host Investor Day on May 22, 2024
May 14, 2024
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Reports First Quarter 2024 Financial Results and Highlights Business Progress
May 07, 2024
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 12, 2024
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Reports Full Year 2023 Financial Results and Highlights Business Progress
March 19, 2024
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock to Participate in Upcoming Investor Conferences
February 28, 2024
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 16, 2024
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Announces the Addition of Katie Peng to Its Board of Directors and Promotes Mo Qatanani, Ph.D. to Chief Scientific Officer
February 15, 2024
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Presents New Preclinical Data Demonstrating Potential Benefit of SRK-439 for Healthy Weight Loss Management
February 06, 2024
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Announces Presentation of New Preclinical Data Evaluating SRK-439 in Obesity at Keystone Symposia
January 25, 2024
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Announces FDA Clearance of IND Application to Initiate Phase 2 Proof-of-Concept Trial with Apitegromab to Treat Obesity
January 23, 2024
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 12, 2024
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock to Present at the 42nd Annual J.P. Morgan Healthcare Conference
December 19, 2023
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 15, 2023
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 17, 2023
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Presents New Data from Phase 1 DRAGON Trial Showing Promising Anti-Tumor Activity in Anti-PD-1 Resistant Metastatic ccRCC Patients and Supporting SRK-181 Continued Tolerability
November 03, 2023
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock to Participate in Upcoming Investor Conferences
November 02, 2023
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock to Host Conference Call to Discuss Third Quarter 2023 Financial Results and Provide Business Update on November 7, 2023
October 23, 2023
From
Scholar Rock
Via
Business Wire
Tickers
SRK
Scholar Rock to Present Clinical and Biomarker Data from the Phase 1 DRAGON Trial at the SITC 38th Annual Meeting
October 19, 2023
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock to Advance Antimyostatin Program to Develop Novel Therapies for Cardiometabolic Disorders
October 11, 2023
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.